Beam Therapeutics's total assets for Q2 2025 were $1.39B, a decrease of -5.16% from the previous quarter. BEAM total liabilities were $344.34M for the fiscal quarter, a 0.16% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.